Adverse events of replacement therapy in children with growth hormone deficiency
Background. The purpose was to analyze and summarize the accumulated short-term and long-term safety data in children with growth hormone deficiency (GHD) treated using recombіnant human growth hormone (rhGH) based on the results of a physical examination, assessment of vital signs, laboratory param...
Main Authors: | M. Aryayev, L. Senkivska |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2023-06-01
|
Series: | Zdorovʹe Rebenka |
Subjects: | |
Online Access: | https://childshealth.zaslavsky.com.ua/index.php/journal/article/view/1598 |
Similar Items
-
Сompliance and barriers to growth hormone therapy in children
by: Liudmyla Senkivska, et al.
Published: (2021-09-01) -
Growth response, psychosocial problems, and quality of life in children with growth hormone deficiency
by: Mykola Aryayev, et al.
Published: (2022-10-01) -
Psycho-Emotional and Behavioral Problems in Children With Growth Hormone Deficiency
by: Mykola Aryayev, et al.
Published: (2021-09-01) -
Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency
by: Shuang Liang, et al.
Published: (2018-04-01) -
Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
by: Hou L, et al.
Published: (2015-12-01)